• Measure Summary
  • NQMC:009930
  • 2014 Nov
  • NQF-Endorsed Measure

Immunizations for adolescents: percentage of adolescents 13 years of age who had one dose of meningococcal vaccine and one tetanus, diphtheria toxoids and acellular pertussis vaccine (Tdap) or one tetanus, diphtheria toxoids vaccine (Td) by their 13th birthday.

National Committee for Quality Assurance

  • Measure Summary
  • NQMC:009961
  • 2014 Nov

Potentially harmful drug-disease interactions in the elderly: percentage of Medicare patients 65 years of age and older who have evidence of an underlying disease, condition or health concern and who were dispensed an ambulatory prescription for a potentially harmful medication, concurrent with or after the diagnosis.

National Committee for Quality Assurance

  • Measure Summary
  • NQMC:009944
  • 2014 Nov
  • NQF-Endorsed Measure

Comprehensive adult diabetes care: percentage of patients 18 to 75 years of age with type 1 or type 2 diabetes who had an eye exam (retinal) performed.

National Committee for Quality Assurance

  • Measure Summary
  • NQMC:009947
  • 2014 Nov
  • NQF-Endorsed Measure

Comprehensive adult diabetes care: percentage of patients 18 to 75 years of age with type 1 or type 2 diabetes who had a foot exam (visual inspection, a sensory exam with monofilament and a pulse exam) during the measurement year.

National Committee for Quality Assurance

  • Measure Summary
  • NQMC:009936
  • 2014 Nov

Appropriate testing for children with pharyngitis: percentage of children 2 to 18 years of age who were diagnosed with pharyngitis, dispensed an antibiotic medication, and received a group A streptococcus (strep) test for the episode.

National Committee for Quality Assurance

  • Measure Summary
  • NQMC:009949
  • 2014 Nov
  • NQF-Endorsed Measure

Osteoporosis management in women who had a fracture: percentage of women 67 to 85 years of age who suffered a fracture and who had either a bone mineral density (BMD) test or prescription for a drug to treat osteoporosis in the six months after the fracture.

National Committee for Quality Assurance

  • Measure Summary
  • NQMC:009964
  • 2014 Nov
  • NQF-Endorsed Measure

Use of high-risk medications in the elderly: percentage of patients 66 years of age and older who received at least one high-risk medication.

National Committee for Quality Assurance

  • Measure Summary
  • NQMC:009933
  • 2014 Nov
  • NQF-Endorsed Measure

Colorectal cancer screening: percentage of patients 50 to 75 years of age who had appropriate screening for colorectal cancer.

National Committee for Quality Assurance

  • Measure Summary
  • NQMC:009919
  • 2014 Nov

Adult body mass index (BMI) assessment: percentage of patients 18 to 74 years of age who had an outpatient visit and whose BMI was documented during the measurement year or the year prior to the measurement year.

National Committee for Quality Assurance

  • Measure Summary
  • NQMC:009954
  • 2014 Nov
  • NQF-Endorsed Measure

Follow-up care for children prescribed ADHD medication (continuation and maintenance [C&M] phase): percentage of patients 6 to 12 years of age as of the index prescription start date with an outpatient ADHD medication who remained on the medication for at least 210 days and who, in addition to the visit in the initiation phase, had at least two follow-up visits with a practitioner within 270 days (9 months) after the initiation phase ended.

National Committee for Quality Assurance

  • Measure Summary
  • NQMC:009939
  • 2014 Nov
  • NQF-Endorsed Measure

Use of spirometry testing in the assessment and diagnosis of COPD: percentage of patients 40 years of age and older with a new diagnosis of COPD or newly active COPD who received appropriate spirometry testing to confirm the diagnosis.

National Committee for Quality Assurance

  • Measure Summary
  • NQMC:009945
  • 2014 Nov
  • NQF-Endorsed Measure

Comprehensive adult diabetes care: percentage of patients 18 to 75 years of age with type 1 or type 2 diabetes who received medical attention for nephropathy.

National Committee for Quality Assurance

  • Measure Summary
  • NQMC:009965
  • 2014 Nov
  • NQF-Endorsed Measure

Use of high-risk medications in the elderly: percentage of patients 66 years of age and older who received at least two different high-risk medications.

National Committee for Quality Assurance

  • Measure Summary
  • NQMC:009931
  • 2014 Nov
  • NQF-Endorsed Measure

Breast cancer screening: percentage of women 50 to 74 years of age who had a mammogram to screen for breast cancer.

National Committee for Quality Assurance

  • Measure Summary
  • NQMC:009934
  • 2014 Nov
  • NQF-Endorsed Measure

Chlamydia screening: percentage of women 16 to 24 years of age who were identified as sexually active and who had at least one test for chlamydia during the measurement year.

National Committee for Quality Assurance

  • Measure Summary
  • NQMC:009940
  • 2014 Nov

Use of appropriate medications for people with asthma: percentage of patients 5 to 64 years of age during the measurement year who were identified as having persistent asthma and who were appropriately dispensed medication during the measurement year.

National Committee for Quality Assurance

  • Measure Summary
  • NQMC:009937
  • 2014 Nov
  • NQF-Endorsed Measure

Appropriate treatment for children with upper respiratory infection (URI): percentage of children 3 months to 18 years of age who were given a diagnosis of URI and were not treated with an antibiotic medication.

National Committee for Quality Assurance

  • Measure Summary
  • NQMC:009920
  • 2014 Nov
  • NQF-Endorsed Measure

Weight assessment for children/adolescents: percentage of patients 3 to 17 years of age who had an outpatient visit with a PCP or OB/GYN and who had evidence of BMI percentile documentation during the measurement year.

National Committee for Quality Assurance

  • Measure Summary
  • NQMC:009950
  • 2014 Nov
  • NQF-Endorsed Measure

Use of imaging studies for low back pain: percentage of patients with a primary diagnosis of low back pain who did not have an imaging study (plain x-ray, MRI, CT scan) within 28 days of the diagnosis.

National Committee for Quality Assurance

  • Measure Summary
  • NQMC:009957
  • 2014 Nov
  • NQF-Endorsed Measure

Annual monitoring for patients on persistent medications: percentage of patients 18 years of age and older who received at least 180 treatment days of ambulatory medication therapy for a select therapeutic agent during the measurement year and had at least one therapeutic monitoring event for the therapeutic agent in the measurement year.

National Committee for Quality Assurance